MedPath

Effect of oral prednizolon versus intratympanic dexamethasone injection on the treatment of patients with sudden sensorineural hearing loss

Phase 3
Completed
Conditions
Sudden sensorineural hearing loss.
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
H90.4
Registration Number
IRCT20120215009014N422
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Age of 18 to 60 years;
Sudden unilateral sensorineural hearing loss during the last 3 weeks;

Exclusion Criteria

Previous hearing loss;
Acoustic abnormality or tumor;
Acute or chronic otitis;
History of ear surgery;
Munir disease;

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hearing threshold. Timepoint: After the first and third months. Method of measurement: Using audiometry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath